AXSM

Axsome Therapeutics Inc
63.20
0.46 (0.73%)

Axsome Therapeutics Inc. (AXSM) Fundamentals

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.
SHARE INFORMATION
Market CapUS$ 2,730,225,273
Shares Outstanding43,516,501
Float35,514,501
Percent Float81.61%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 50,037,106
Latest Fiscal EPSUS$ -4.59
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions431
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months5,905,038
Institutional Holdings Percent102.1%
Institutional Sold Previous 3 Months4,305,947
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months17,501
Insider Holdings Percent0.5
Insider Sold Previous 3 Months17,501
Insider Shares Owned214,253
TRADING INFO
52 Week HighUS$ 82.00
52 Week LowUS$ 20.63
52 Week High ChangeUS$ 83.56
21 Day Moving AverageUS$ 63.5876
21 Day Extended Moving AverageUS$ 63.6697
50 Day Moving AverageUS$ 66.0702
50 Day Extended Moving AverageUS$ 65.1465
200 Day Moving AverageUS$ 54.8915
200 Day Extended Moving AverageUS$ 57.4885
10 Day Average Volume1,020,288
20 Day Average Volume1,012,886
30 Day Average Volume1,028,911
50 Day Average Volume1,008,143
Alpha0.095384
Beta1.9451
Standard Deviation0.412816
R20.064380
7 Day Price ChangeUS$ 4.35
7 Day Percent Change7.45%
21 Day Price ChangeUS$ 1.69
21 Day Percent Change2.77%
30 Day Price ChangeUS$ -3.88
30 Day Percent Change-5.82%
Month to Date Price ChangeUS$ -5.45
Month to Date Percent Change-7.99%
Quarter to Date Price ChangeUS$ -14.39
Quarter to Date Percent Change-18.66%
180 Day Price ChangeUS$ 3.54
180 Day Percent Change5.98%
200 Day Price ChangeUS$ -1.51
200 Day Percent Change-2.35%
Year to Date Price ChangeUS$ -14.39
Year to Date Percent Change-18.66%

Axsome Therapeutics Inc. (AXSM) Key Ratios

PROFITABILITY
EBIT Margin-594.1%
EBITDA Margin-579.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin89.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 50,037,106
Revenue Per ShareUS$ 1.1498
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book69.00
Total Debt To Equity0.90
Int Coverage-24.50
Current Ratio2.50
Leverage Ratio3.10
Quick Ratio2.50
Long Term Debt To Capital0.46
VALUATION MEASURES
PE Ratio-15.00
Enterprise ValueUS$ 2,624,066,878
Price to Sales54.564
Price to Free Cash-16.00
PE High Last 5 Years-4.50
Price To Book24.90
Price To Cash Flow0.00
PE Low Last 5 Years-17.60
Price to Tangible Book69.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.60
Invoice Turnover1.70
Assets Turnover0.20
Return Assets-90.34
Return on Equity-301.10
Return on Capital-88.54

Axsome Therapeutics Inc. (AXSM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOHerriot Tabuteau
Emplyoees383
Last AuditUQ
CIK0001579428
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address22 Cortlandt Street
16th Floor
New York, NY 10007
Websitehttps://www.axsome.com
Facsimile+1 212 320-0245
Telephone+1 212 332-3241
Emailmjacobson@axsome.com
Your Recent History
NASDAQ
AXSM
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230321 02:13:14